ArticleTropical animal health and production2026
Innovative nanotechnology approach using salicylic acid loaded chitosan nanoparticles to improve post-thaw sperm function, reduce apoptosis, and preserve ultrastructure in rams.
Article in Tropical animal health and production, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study was designed to determine whether salicylic acid-chitosan nanoparticles (SA-CNPs) added to a semen freezing extender could enhance post-thaw sperm quality and functionality in Rahmani rams, with a particular focus on oxidative stress, apoptosis, microbial contamination, and ultrastructural preservation. Semen was collected from six healthy rams over eight weeks, pooled, and cryopreserved in extenders containing different concentrations of SA-CNPs (0, 5, 10, 20, and 40 µM). Post-thaw analyses demonstrated that SA-CNPs significantly improved progressive motility, viability, and membrane integrity compared with controls (p < 0.05). Quadratic regression analysis revealed a dose-dependent response, with predicted optimal improvement in sperm quality observed at 30 µM. Sperm kinematics showed highest values in samples treated with 20 µM SA-CNPs. Acrosome reaction analysis showed more live sperm with intact acrosomes and fewer live or dead sperm with damaged acrosomes, peaking at 20-40 µM. Antioxidant defense was improved, with higher total antioxidant capacity, increased nuclear factor erythroid 2-related factor 2 and its downstream enzymes (catalase, glutathione peroxidase 1, superoxide dismutase1), alongside reductions in oxidative stress markers, with the strongest effects observed at 20 µM. Apoptotic markers were favorably modulated, as evidenced by reduced caspase-3 levels, increased Bcl-2 expression, and a decreased apoptotic sperm percentage. These effects followed a quadratic dose-response pattern, peaking at 30 µM, while Bax expression declined progressively with increasing SA-CNPs concentration. Additionally, SA-CNPs reduced total bacterial and coliform counts and preserved sperm ultrastructure, including plasma membrane, acrosomal cap, and mitochondria. Collectively, these results indicate that SA-CNPs supplementation enhances post-thaw sperm function, strengthens antioxidant defenses, mitigates apoptosis, reduces microbial contamination, and protects ultrastructure, with 20-30 µM identified as the optimal concentration range for maximal cryoprotective and functional benefits.
Indexed as
Identifiers
42484752What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.